← All verdicts
Verdict

Deep Undervalued

Every analyzed stock in Deep Undervalued — 1,156 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Deep Undervalued" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 0.8 (our deep-undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Robust Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +23.6 pts (608 entries, 188 companies, very unlikely to be luck). 57% of entries beat the S&P; 30% beat it by 30 points or more; 25% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +21.9 pts.
+23.6 ptsvs S&P, average
57%beat the S&P
30%up 30+ pts vs S&P
25%down 20+ pts vs S&P
+24.1 ptsvs small caps, 12 mo
−16.1 pts 2023worst year to buy ?
6.0luck check ?
Does the holding period matter?3 mo: +4.9 pts 52% beat6 mo: +9.1 pts 54% beat12 mo: +23.6 pts 57% beat24 mo: +35.1 pts 52% beat3 yr, per yr: +6.5 pts 46% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today522+15.2 pts t 5.1+16.9 pts
Sell-off (S&P ≥10% off high)86+74.7 pts t 3.7+67.9 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing195+23.5 pts t 4.1+3.4 pts
Other64+13.8 pts t 2.0+9.3 pts
Tech hardware & semis54+14.9 pts t 1.1+2.6 pts
Energy51+27.4 pts t 2.0+4.8 pts
Retail & consumer33+33.7 pts t 2.2+21.4 pts
Services33+13.4 pts t 2.1+18.5 pts
Construction28+19.9 pts t 2.0+3.7 pts
Finance & real estate28+4.9 pts t 0.7+3.1 pts

Holds up out of sample? Before 2018: +17.1 pts (n 274, t 5.9). From 2018: +29.0 pts (n 334, t 4.3). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+8 pts+4 pts+16 pts+28 pts+12 pts+2 pts+28 pts+22 pts−2 pts−12 pts+119 pts+18 pts+26 pts−16 pts−0 pts+36 pts
n9245638293651312743672630454650

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
BHC
Bausch Health Companies Inc.
Deeply undervalued
Healthcare Risk 41 · Elevated
Price$5.86
Model IV$45.96
P/IV0.12
Discount 87% Return to IV: +684.3%
Market implies -24.9%/yr vs model +6.5% · below model
BHF
Brighthouse Financial, Inc.
Deeply undervalued
Financial Services Risk 38 · Moderate
Price$50.11
Model IV$109.81
P/IV0.57
Discount 54% Return to IV: +119.1%
BHFAL
Brighthouse Financial, Inc.
Deeply undervalued
Financial Services Risk 27 · Moderate
Price$15.20
Model IV$102.12
P/IV0.16
Discount 85% Return to IV: +571.9%
BHFAM
Brighthouse Financial, Inc.
Deeply undervalued
Financial Services Risk 38 · Moderate
Price$9.77
Model IV$102.12
P/IV0.11
Discount 90% Return to IV: +945.3%
BHFAN
Brighthouse Financial, Inc.
Deeply undervalued
Financial Services Risk 42 · Elevated
Price$11.02
Model IV$102.12
P/IV0.12
Discount 89% Return to IV: +826.7%
BHFAO
Brighthouse Financial, Inc.
Deeply undervalued
Financial Services Risk 42 · Elevated
Price$14.07
Model IV$102.12
P/IV0.15
Discount 86% Return to IV: +626.1%
BHFAP
Brighthouse Financial, Inc.
Deeply undervalued
Financial Services Risk 27 · Moderate
Price$13.75
Model IV$102.12
P/IV0.15
Discount 87% Return to IV: +642.7%
BHST
BIOHARVEST SCIENCES INC.
Deeply undervalued
Healthcare Risk 32 · Moderate
Price$1.85
Model IV$9.07
P/IV0.43
Discount 80% Return to IV: +390.2%
Market implies -30.1%/yr vs model +50.0% · below model
BKD
Brookdale Senior Living Inc.
Deeply undervalued
Healthcare Risk 51 · Elevated
Price$12.14
Model IV$31.15
P/IV0.41
Discount 61% Return to IV: +156.6%
Market implies -18.9%/yr vs model +3.7% · below model
BLKB
BLACKBAUD INC
Undervalued
Technology Risk 42 · Elevated
Price$45.67
Model IV$62.81
P/IV0.49
Discount 27% Return to IV: +37.5%
Market implies +0.8%/yr vs model +7.1% · below model
BLMN
Bloomin' Brands, Inc.
Deeply undervalued
Consumer Cyclical Risk 38 · Moderate
Price$8.69
Model IV$14.23
P/IV0.59
Discount 39% Return to IV: +63.7%
Market implies -2.9%/yr vs model +7.0% · below model
BLNK
Blink Charging Co.
Deeply undervalued
Technology Risk 29 · Moderate
Price$0.54
Model IV$3.05
P/IV0.27
Discount 82% Return to IV: +460.7%
Market implies -28.9%/yr vs model +49.1% · below model
BMBL
Bumble Inc.
Deeply undervalued
Technology Risk 41 · Elevated
Price$2.99
Model IV$37.89
P/IV0.08
Discount 92% Return to IV: +1,167.2%
Market implies -34.4%/yr vs model +11.9% · below model
BMRN
BIOMARIN PHARMACEUTICAL INC
Deeply undervalued
Healthcare Risk 30 · Moderate
Price$65.68
Model IV$99.93
P/IV0.57
Discount 34% Return to IV: +52.1%
Market implies +5.1%/yr vs model +13.5% · below model
BMY
BRISTOL MYERS SQUIBB CO
Deeply undervalued
Healthcare Risk 36 · Moderate
Price$63.64
Model IV$174.33
P/IV0.33
Discount 63% Return to IV: +173.9%
Market implies -7.4%/yr vs model +6.1% · below model
BNED
Barnes & Noble Education, Inc.
Deeply undervalued
Consumer Cyclical Risk 45 · Elevated
Price$11.23
Model IV$16.41
P/IV0.63
Discount 32% Return to IV: +46.2%
Market implies -3.5%/yr vs model +2.0% · below model
BNGO
Bionano Genomics, Inc.
Deeply undervalued
Healthcare Risk 27 · Moderate
Price$1.56
Model IV$4.48
P/IV0.28
Discount 65% Return to IV: +187.0%
Market implies -23.0%/yr vs model +12.2% · below model
BNL
Broadstone Net Lease, Inc.
Deeply undervalued
Financial Services Risk 33 · Moderate
Price$19.97
Model IV$29.56
P/IV0.68
Discount 32% Return to IV: +48.0%
BNT
Brookfield Wealth Solutions Ltd.
Deeply undervalued
Financial Services Risk 23 · Moderate
Price$38.19
Model IV$68.85
P/IV0.66
Discount 45% Return to IV: +80.3%
BNZI
Banzai International, Inc.
Deeply undervalued
Technology Risk 37 · Moderate
Price$1.70
Model IV$6.99
P/IV0.56
Discount 76% Return to IV: +311.2%
Market implies -31.6%/yr vs model +15.0% · below model
BOLT
Bolt Biotherapeutics, Inc.
Deeply undervalued
Healthcare Risk 34 · Moderate
Price$3.95
Model IV$28.19
P/IV0.19
Discount 86% Return to IV: +613.7%
Market implies -42.8%/yr vs model +50.0% · below model
BON
Bon Natural Life Ltd
Deeply undervalued
Healthcare Risk 30 · Moderate
Price$1.11
Model IV$9.71
P/IV0.13
Discount 89% Return to IV: +775.0%
Market implies -50.0%/yr vs model +2.0% · below model
BOOM
DMC Global Inc.
Deeply undervalued
Basic Materials Risk 32 · Moderate
Price$6.36
Model IV$21.08
P/IV0.32
Discount 70% Return to IV: +231.4%
Market implies -13.9%/yr vs model +8.0% · below model
BOSC
BOS BETTER ONLINE SOLUTIONS LTD
Deeply undervalued
Technology Risk 24 · Moderate
Price$4.66
Model IV$14.96
P/IV0.27
Discount 69% Return to IV: +220.9%
Market implies -10.4%/yr vs model +11.1% · below model
BPOPM
POPULAR, INC.
Deeply undervalued
Financial Services Risk 27 · Moderate
Price$25.20
Model IV$138.77
P/IV0.18
Discount 82% Return to IV: +450.7%
BQ
Boqii Holding Ltd
Valuation N/A
Consumer Cyclical Risk 41 · Elevated
Price$0.85
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
BR
BROADRIDGE FINANCIAL SOLUTIONS, INC.
Deeply undervalued
Technology Risk 30 · Moderate
Price$167.74
Model IV$274.10
P/IV0.56
Discount 39% Return to IV: +63.4%
Market implies +1.3%/yr vs model +9.5% · below model
BRBR
BELLRING BRANDS, INC.
Deeply undervalued
Consumer Defensive Risk 33 · Moderate
Price$9.14
Model IV$71.33
P/IV0.12
Discount 87% Return to IV: +680.4%
Market implies -16.8%/yr vs model +13.2% · below model
BRCC
BRC Inc.
Deeply undervalued
Consumer Defensive Risk 33 · Moderate
Price$8.56
Model IV$3.26
P/IV0.39
Premium +162% Return to IV: -61.9%
Market implies +10.1%/yr vs model +14.3% · below model
BRID
BRIDGFORD FOODS CORP
Deeply undervalued
Consumer Defensive Risk 34 · Moderate
Price$5.98
Model IV$24.60
P/IV0.32
Discount 76% Return to IV: +311.4%
Market implies -31.3%/yr vs model +2.0% · below model
BRKR
BRUKER CORP
Deeply undervalued
Healthcare Risk 48 · Elevated
Price$53.43
Model IV$35.96
P/IV0.51
Premium +49% Return to IV: -32.7%
Market implies +6.2%/yr vs model +9.2% · below model
BRLT
Brilliant Earth Group, Inc.
Valuation N/A
Consumer Cyclical Risk 40 · Elevated
Price$1.41
Model IV—
P/IV—
Market implies -30.9%/yr vs model +4.9% · below model
BRSP
BrightSpire Capital, Inc.
Deeply undervalued
Financial Services Risk 38 · Moderate
Price$4.45
Model IV$11.82
P/IV0.49
Discount 62% Return to IV: +165.6%
BRZE
Braze, Inc.
Deeply undervalued
Technology Risk 30 · Moderate
Price$23.94
Model IV$39.57
P/IV0.65
Discount 39% Return to IV: +65.3%
Market implies -8.8%/yr vs model +32.7% · below model
BSX
BOSTON SCIENTIFIC CORP
Deeply undervalued
Healthcare Risk 29 · Moderate
Price$42.98
Model IV$105.68
P/IV0.46
Discount 59% Return to IV: +145.9%
Market implies -0.7%/yr vs model +12.8% · below model
BTBD
BT Brands, Inc.
Deeply undervalued
Consumer Cyclical Risk 32 · Moderate
Price$1.74
Model IV$1.89
P/IV0.60
Discount 8% Return to IV: +8.6%
Market implies +0.0%/yr vs model +32.4% · below model
BTCO
Invesco Galaxy Bitcoin ETF
Deeply undervalued
Financial Services Risk 35 · Moderate
Price$76.86
Model IV$116.18
P/IV0.63
Discount 34% Return to IV: +51.2%
BTMD
biote Corp.
Deeply undervalued
Healthcare Risk 40 · Elevated
Price$1.33
Model IV$7.84
P/IV0.26
Discount 83% Return to IV: +489.2%
Market implies -24.2%/yr vs model +8.9% · below model
BTU
PEABODY ENERGY CORP
Deeply undervalued
Energy Risk 43 · Elevated
Price$27.35
Model IV$45.65
P/IV0.59
Discount 40% Return to IV: +66.9%
Market implies -3.2%/yr vs model +3.9% · below model
BULL
Webull Corp
Deeply undervalued
Financial Services Risk 26 · Moderate
Price$9.22
Model IV$11.56
P/IV0.55
Discount 20% Return to IV: +25.4%
Market implies +6.2%/yr vs model +12.0% · below model
BWIN
Baldwin Insurance Group, Inc.
Deeply undervalued
Financial Services Risk 35 · Moderate
Price$32.00
Model IV$108.40
P/IV0.18
Discount 70% Return to IV: +238.8%
Market implies -25.8%/yr vs model +27.4% · below model
BXC
BlueLinx Holdings Inc.
Deeply undervalued
Industrials Risk 41 · Elevated
Price$79.76
Model IV$126.84
P/IV0.41
Discount 37% Return to IV: +59.0%
Market implies -10.5%/yr vs model +0.0% · below model
BYD
BOYD GAMING CORP
Deeply undervalued
Consumer Cyclical Risk 41 · Elevated
Price$77.15
Model IV$132.68
P/IV0.62
Discount 42% Return to IV: +72.0%
Market implies +1.0%/yr vs model +9.9% · below model
BYFC
BROADWAY FINANCIAL CORP DE
Deeply undervalued
Financial Services Risk 38 · Moderate
Price$11.85
Model IV$16.90
P/IV0.57
Discount 30% Return to IV: +42.6%
BYRN
Byrna Technologies Inc.
Deeply undervalued
Technology Risk 33 · Moderate
Price$3.62
Model IV$14.45
P/IV0.43
Discount 75% Return to IV: +299.2%
Market implies -25.2%/yr vs model +29.4% · below model
BZH
BEAZER HOMES USA INC
Deeply undervalued
Industrials Risk 34 · Moderate
Price$33.25
Model IV$46.21
P/IV0.55
Discount 28% Return to IV: +39.0%
Market implies -3.7%/yr vs model +2.6% · below model
CABO
Cable One, Inc.
Valuation N/A
Communication Services Risk 44 · Elevated
Price$21.31
Model IV—
P/IV—
Market implies -50.0%/yr vs model +6.1% · below model
CACC
CREDIT ACCEPTANCE CORP
Deeply undervalued
Financial Services Risk 37 · Moderate
Price$604.24
Model IV$1,312.64
P/IV0.44
Discount 54% Return to IV: +117.2%
Market implies -3.2%/yr vs model +10.4% · below model
CAG
CONAGRA BRANDS INC.
Deeply undervalued
Consumer Defensive Risk 33 · Moderate
Price$14.60
Model IV$63.78
P/IV0.21
Discount 77% Return to IV: +336.8%
Market implies -16.0%/yr vs model +3.0% · below model
CAH
CARDINAL HEALTH INC
Undervalued
Consumer Defensive Risk 40 · Elevated
Price$232.65
Model IV$296.64
P/IV0.66
Discount 22% Return to IV: +27.5%
Market implies +5.8%/yr vs model +11.2% · below model
CAI
Caris Life Sciences, Inc.
Deeply undervalued
Healthcare Risk 32 · Moderate
Price$24.34
Model IV$37.69
P/IV0.44
Discount 35% Return to IV: +54.8%
Market implies -5.8%/yr vs model +50.0% · below model
CALM
CAL-MAINE FOODS INC
Deeply undervalued
Basic Materials Risk 30 · Moderate
Price$74.39
Model IV$176.07
P/IV0.42
Discount 58% Return to IV: +136.7%
Market implies -4.6%/yr vs model +8.0% · below model
CAPL
CrossAmerica Partners LP
Deeply undervalued
Consumer Defensive Risk 43 · Elevated
Price$22.80
Model IV$31.81
P/IV0.68
Discount 28% Return to IV: +39.5%
Market implies -2.3%/yr vs model +3.0% · below model
CAR
AVIS BUDGET GROUP, INC.
Deeply undervalued
Industrials Risk 37 · Moderate
Price$121.74
Model IV$1,902.84
P/IV0.10
Discount 94% Return to IV: +1,463.0%
Market implies -38.4%/yr vs model +9.8% · below model
CARG
CarGurus, Inc.
Deeply undervalued
Technology Risk 30 · Moderate
Price$34.43
Model IV$45.71
P/IV0.65
Discount 25% Return to IV: +32.8%
Market implies +1.8%/yr vs model +6.8% · below model
CARL
CARLSMED, INC.
Deeply undervalued
Healthcare Risk 31 · Moderate
Price$14.73
Model IV$17.56
P/IV0.65
Discount 16% Return to IV: +19.2%
Market implies -1.9%/yr vs model +50.0% · below model
CARS
Cars.com Inc.
Deeply undervalued
Technology Risk 39 · Moderate
Price$11.71
Model IV$28.25
P/IV0.36
Discount 59% Return to IV: +141.3%
Market implies -6.4%/yr vs model +9.2% · below model
CART
Maplebear Inc.
Deeply undervalued
Technology Risk 30 · Moderate
Price$51.07
Model IV$95.23
P/IV0.42
Discount 46% Return to IV: +86.5%
Market implies +5.2%/yr vs model +17.3% · below model
CBAT
CBAK Energy Technology, Inc.
Undervalued
Technology Risk 34 · Moderate
Price$1.00
Model IV$1.35
P/IV0.59
Discount 26% Return to IV: +35.2%
Market implies +12.5%/yr vs model +25.0% · below model
CBZ
CBIZ, Inc.
Deeply undervalued
Technology Risk 26 · Moderate
Price$54.54
Model IV$123.88
P/IV0.27
Discount 56% Return to IV: +127.1%
Market implies +4.8%/yr vs model +21.6% · below model